Yuri Antes

FDA
Uncategorized

FDA approves first IDH-targeted glioma drug

September 12, 2024

Nature Biotechnology, Published online: 13 September 2src24; doi:1src.1src38/s41587-src24-src24src8-8FDA approves first IDH-targeted glioma drug...Read More

Yuri Antes

FDA approves first IDH-targeted glioma drug

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

Summer COVID surge isn’t cause for alarm, experts say

Budget FY25: Pharmaceuticals sector needs a major boost with increased focus on R&D and innovation

Dental veneers: Everything you need to know

Cheeky diet soft drink getting you through the work day? Here’s what that may mean for your health

UK teenagers get two-thirds of their calories from ultra-processed foods—new study

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories